This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignee: Ep Pharma, LLC. Active years: 2017-2020.
Company Filing History:
Years Active: 2017-2020
Title: Innovations by Christopher L Pelloni
Introduction
Christopher L Pelloni is an accomplished inventor based in Newtown, PA (US). He has made significant contributions to the field of cannabinoid formulations, holding a total of 4 patents. His work focuses on innovative methods for the inhalation of cannabinoid materials, which have the potential to impact the medical and wellness industries.
Latest Patents
Pelloni's latest patents include groundbreaking formulations for cannabinoid inhalation. One of his notable inventions is a cannabinoid active agent containing formulation that comprises the active agent, an HFA propellant, and optionally a terpenoid and a co-solvent. This formulation requires at least two cannabinoids, each present in amounts of at least 20% of the total cannabinoid content. Additionally, he has developed a low-temperature inhalation method that allows for the administration of cannabinoid entities without the use of heat greater than 40°C. Another patent focuses on a cannabinoid material as an active agent, which also utilizes an HFA propellant and a co-solvent, with a method of administration that avoids heat greater than 50°C.
Career Highlights
Christopher L Pelloni is currently associated with Ep Pharma, LLC, where he continues to innovate in the field of cannabinoid research. His work is characterized by a commitment to developing safe and effective inhalation methods for cannabinoid delivery.
Collaborations
Pelloni collaborates with Charles Raymond Eck, contributing to the advancement of cannabinoid formulations and their applications.
Conclusion
Christopher L Pelloni's contributions to cannabinoid formulations demonstrate his innovative spirit and dedication to improving inhalation methods. His patents reflect a significant advancement in the field, paving the way for future developments in cannabinoid therapies.